STAA News Alert Staar Surgical Company (STAA) 6.76 02/13/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Staar Surgical Company (STAA) 6.76 $STAA

STAAR Surgical Announces Fourth Quarter 2014 Results Release Date, Conference Call And Webcast
PR Newswire - Fri Feb 13, 6:00AM CST
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and delivery systems for the eye, today announced that it will release its financial results for the fourth quarter ended January 2, 2015 on Wednesday, February 25, 2015 after the market close.
STAA: 6.76 (-0.02)

Staar Surgical not quite there on GMP audit
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 6:22AM CST

STAA: 6.76 (-0.02)

Shares of STAA Down 51.9% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Feb 03, 4:58PM CST
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 7 months, STAAR Surgical has returned 51.87% as of today's recent price of $6.68.
STAA: 6.76 (-0.02)

STAAR Surgical (STAA) in Focus: Stock Moves 7.5% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 8:25AM CST
STAAR Surgical (STAA) was a big mover last session, with shares rising roughly 8% on the day.
BRLI: 34.63 (+0.06), STAA: 6.76 (-0.02)

Market Maker Surveillance Report. RUSS, ETH, STAA, NBG, USEL, STRL, Losing Stocks With Lowest Price Friction For Tuesday, January 27th 2015
M2 - Wed Jan 28, 3:15AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 5094 companies with "abnormal" market making, 2629 companies with positive Friction Factors and 3365 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Direxion Daily Russia Bear 3X Shares (NYSE:RUSS), Ethan Allen Interiors Inc (NYSE:ETH), Staar Surgical Co (NASDAQ:STAA), National Bank of Greece SA (NYSE:NBG), U S ELECTRONICS GROU (OTC:USEL), Sterling Construction Co Inc (NASDAQ:STRL). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
ETH: 27.00 (-0.24), STAA: 6.76 (-0.02), RUSS: 11.59 (-0.81), NBG: 1.61 (+0.18), STRL: 2.99 (unch)

Nasdaq stocks posting largest volume increases
AP - Tue Jan 27, 5:09PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
BLVD: 9.73 (+0.04), HTBX: 5.83 (+0.22), GLBZ: 12.65 (+0.35), LSCC: 6.10 (+0.02), SAL: 28.70 (unch), CRDS: 2.32 (+0.05), WVFC: 11.02 (-0.45), CRRC: 22.96 (+0.22), AMRB: 9.59 (-0.06), NFEC: 2.11 (+0.02), STAA: 6.76 (-0.02), SIMG: 7.25 (-0.01), SBSI: 29.39 (-0.01), UPI: 1.27 (unch), RITT: 1.29 (unch)

Nasdaq stocks posting largest percentage decreases
AP - Tue Jan 27, 5:09PM CST
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
EGLE: 9.98 (-0.02), JJSF: 100.08 (-0.44), BRID: 7.55 (-0.04), FCFS: 48.92 (+0.25), EPRS: 7.67 (+0.67), NVC.TO: 11.27 (-0.23), TLOG: 5.12 (+0.36), OMER: 20.63 (+0.13), ABTL: 9.88 (+0.13), IESC: 7.84 (+0.01), STAA: 6.76 (-0.02), MSFT: 43.87 (+0.78), NVCN: 9.08 (-0.17), DXM: 7.08 (-0.03), YNDX: 17.00 (+0.59), SANM: 22.50 (+0.07)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 11:40AM CST

HEAR: 2.54 (-0.14), NES: 3.52 (+0.13), ADXS: 7.18 (+0.06), ZIOP: 9.64 (-0.35), EXXI: 4.00 (+0.42), JJSF: 100.08 (-0.44), DRAM: 2.39 (-0.04), EPRS: 7.67 (+0.67), CRDS: 2.32 (+0.05), NBG: 1.61 (+0.18), CRRC: 22.96 (+0.22), STRL: 2.99 (unch), NFEC: 2.11 (+0.02), COMM: 30.40 (+0.17), SIMG: 7.25 (-0.01), STAA: 6.76 (-0.02), MSFT: 43.87 (+0.78), PLT: 49.95 (+0.71), SANM: 22.50 (+0.07), IFON: 1.48 (+0.02)

STAAR Surgical Shares Down 60.4% Since SmarTrend's Sell Call (STAA)
Comtex SmarTrend(R) - Tue Jan 27, 11:09AM CST
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 7 months, STAAR Surgical has returned 60.37% as of today's recent price of $5.50.
STAA: 6.76 (-0.02)

STAAR Surgical plummets on lower guidance
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 9:10AM CST

STAA: 6.76 (-0.02)

STAAR Surgical Has Returned 47.3% Since SmarTrend Recommendation (STAA)
Comtex SmarTrend(R) - Tue Jan 20, 9:43AM CST
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 7 months, STAAR Surgical has returned 47.26% as of today's recent price of $7.32.
STAA: 6.76 (-0.02)

Shares of STAA Down 37.8% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 13, 9:38AM CST
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 6 months, STAAR Surgical has returned 37.75% as of today's recent price of $8.64.
STAA: 6.76 (-0.02)

STAAR Surgical Has Returned 34.5% Since SmarTrend Recommendation (STAA)
Comtex SmarTrend(R) - Mon Jan 05, 4:48PM CST
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 6 months, STAAR Surgical has returned 34.51% as of today's recent price of $9.09.
STAA: 6.76 (-0.02)

STAAR Surgical Down to Strong Sell on Persistent Headwinds - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 29, 1:50PM CST
On Dec 27, 2014, Zacks Investment Research downgraded STAAR Surgical Company (STAA) to a Zacks Rank #5 (Strong Sell)
ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), ALGN: 56.90 (-0.34), STAA: 6.76 (-0.02)

Downtrend Call Working As STAAR Surgical Stock Falls 34.0% (STAA)
Comtex SmarTrend(R) - Mon Dec 29, 9:38AM CST
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 6 months, STAAR Surgical has returned 34.01% as of today's recent price of $9.16.
STAA: 6.76 (-0.02)

STAAR Surgical Shares Down 34.3% Since SmarTrend's Sell Call (STAA)
Comtex SmarTrend(R) - Fri Dec 12, 4:42PM CST
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 5 months, STAAR Surgical has returned 34.29% as of today's recent price of $9.12.
STAA: 6.76 (-0.02)

33.3% Return Seen to Date on SmarTrend STAAR Surgical Call (STAA)
Comtex SmarTrend(R) - Fri Dec 05, 10:56AM CST
SmarTrend identified a Downtrend for STAAR Surgical (NASDAQ:STAA) on July 7th, 2014 at $13.88. In approximately 5 months, STAAR Surgical has returned 33.29% as of today's recent price of $9.26.
STAA: 6.76 (-0.02)

Zacks' Bear Of The Day: STAAR Surgical
Zacks Investment Research - Seeking Alpha - Wed Dec 03, 11:55AM CST
STAAR Surgical ( STAA ) recently reported disappointing third-quarter results, as the company missed expectations for both sales and earnings. Analysts have revised their estimates sharply lower for both this year and next, sending the stock to a...
STAA: 6.76 (-0.02)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 8

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Purlin's Patent: Transforming Real Estate Deals

Updated Category News Views 1

Purlin's Game-Changer: A Patent in Real Estate Real estate has been chugging along like a stubborn mule, dragging deals through opaque negotiations and haphazard guessing games. Then enters Final Offer from Purlin Enterprises, waving a newly granted patent like a shiny golden ticket to those stuck trading homes in the dark. Leveling the Playing Field with Transparency In...

Continue Reading
Mastering Power Efficiency with Phase Converters

Updated Category News Views 1

Powering Multiple Machines: A New Approach? You ever look at a workshop crammed with machines and wonder if it's all a waste of space, time, and money? Jay Yuergens from North America Phase Converter Co. gives us the lowdown on how one rotary or digital phase converter can handle the load. And let me tell you, it ain't as crazy as it sounds. It's all about finesse and...

Continue Reading
Cruise Planners Sets AI Benchmark in Travel Innovs

Updated Category News Views 11

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Continue Reading
De¹ Unveils Tokenization Model on BNB Chain

Updated Category News Views 15

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Continue Reading
Flotek Faces Class Action as PREPA Contract Dissolves

Updated Category News Views 0

Flotek's 10-Year Project Shattered by Canceled Agreement Here's a brew you won't find down at any greasy spoon: Flotek Industries (NYSE: FTK) finds itself tangled in a legal web after their highly touted project in Puerto Rico went belly-up. That's one heck of a slice off their revenue pie, and investors best have their radar turned on. The lawsuit's all about what's...

Continue Reading
Workday Hits High Note in 2026 Gartner Magic Quadrant

Updated Category News Views 14

Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...

Continue Reading
Ball Corp's Leadership Shuffle Aims for Strategic Gains

Updated Category News Views 9

Leadership Changes in the Midst of Market Challenges You don't need a crystal ball to see that leadership changes can signal either turmoil or opportunity. Ball Corporation, a titan in the realm of aluminum packaging, is experiencing a shake-up at the top of its beverage packaging business units. With Carey Causey stepping into the role for North and Central America, and...

Continue Reading
Standex's New Financial Lead: Stoddard Takes Helm

Updated Category News Views 9

New Financial Captain Aboard Standex's Ship Alright, here's something that'll have investors nodding along with interest: Standex International has just named Samantha L. Stoddard as their incoming Chief Financial Officer and Treasurer, effective December 1, 2026. Now, Standex isn't some scrappy upstart. We're talking about a veteran manufacturer intricately working...

Continue Reading
Florida Cancer Center Expands Expertise with New Oncologist

Updated Category News Views 11

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Continue Reading

Top 5 Most Recently Viewed Articles

Job Market Insights: Anticipation Builds as Reports Loom

Updated Category News Views 239

Overview of Upcoming Job Reports As the job market continues to be a significant focus for investors and economists alike, there is growing anticipation surrounding a crucial jobs report from the Bureau of Labor Statistics. Scheduled for release on Friday morning, this report is expected to shape economic forecasts and market reactions. What to Expect from the Jobs Report...

Continue Reading
Enterprise Financial Services Corp Announces Q4 Earnings Call Details

Updated Category News Views 96

Join the Upcoming Conference Call for Q4 2024 Earnings Enterprise Financial Services Corp (Nasdaq: EFSC) is set to announce its financial results for the fourth quarter of 2024. This eagerly anticipated release is scheduled for the final days of January. Finance enthusiasts and stakeholders are encouraged to tune into the conference call and webcast where they can gain...

Continue Reading
Wearable Devices Secures $4 Million in Innovative Funding

Updated Category News Views 224

Wearable Devices Announces Successful Funding Initiative Yokneam Illit, Israel – In a significant milestone, Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW), renowned for their groundbreaking artificial intelligence (AI) technology that powers touchless sensing wearables, has successfully initiated a securities purchase agreement. This agreement involves the sale of 670,000...

Continue Reading
Potential Growth for First Solar Stocks Amid Declining Price

Updated Category News Views 122

Firm Outlook as First Solar Prepares for Earnings Report First Solar Inc (NASDAQ: FSLR) is preparing to reveal its fourth-quarter earnings. Analysts predict earnings per share (EPS) to come in at $4.71, while overall revenues are expected to reach $1.47 billion. These figures are set to be announced after market hours, creating significant anticipation among investors....

Continue Reading
Candel Therapeutics Reports Promising Results for Cancer Treatment

Updated Category News Views 246

Candel Therapeutics Publishes Clinical Trial Findings In an exciting development for cancer treatment, Candel Therapeutics, Inc. (Nasdaq: CADL), a clinical stage biopharmaceutical company specializing in innovative immunotherapies, has announced the publication of their phase 1b clinical trial results. This landmark study investigated the safety and tolerability of...

Continue Reading